Concepedia

Jefferson R. McCowan

JR

Statistics

Publications

16

Citations

652

H-Index

13

Active since

1987

Affiliations

Eli Lilly (United States)(Current)

Jefferson R. McCowan is an author at Eli Lilly (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1987–2003

16

Publications

16

Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain

J. Scott Sawyer, Bryan D. Anderson, Douglas W. Beight et al. · Journal of Medicinal Chemistry · 2003 · 237 citations · Full text

, , +17

Quinazolinone cholecystokinin-B receptor ligands

Melvin J. Yu, K. Jeff Thrasher, Jefferson R. McCowan et al. · Journal of Medicinal Chemistry · 1991 · 63 citations · Full text

, , +10

Dibasic Benzo[<i>b</i>]thiophene Derivatives as a Novel Class of Active Site-Directed Thrombin Inhibitors. 1. Determination of the Serine Protease Selectivity, Structure−Activity Relationships, and Binding Orientation

Daniel J. Sall, Jolie Bastian, John A. Buben et al. · Journal of Medicinal Chemistry · 1997 · 54 citations

, , +10

Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents

Melvin J. Yu, Jefferson R. McCowan, K. Jeff Thrasher et al. · Journal of Medicinal Chemistry · 1992 · 45 citations

, , +17

Synthesis and x-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands

Melvin J. Yu, Jefferson R. McCowan, Norman R. Mason et al. · Journal of Medicinal Chemistry · 1992 · 37 citations · Full text

, , +15

1–5 of 16